Hemostatic powder noninferior in nonvariceal upper GI bleeds
TC-325 hemostatic powder compares well with standard endoscopic treatment of acute nonvariceal gastrointestinal bleeding in a new study.
Antibiotics vs. placebo in acute uncomplicated diverticulitis
Does antibiotic therapy decrease length of hospital stay for patients with acute uncomplicated diverticulitis?
Tranexamic acid does not reduce risk of death in GI bleed
In patients with GI bleeding, does high-dose tranexamic acid (TXA) reduce the risk of death?
Oakland score identifies patients with lower GI bleed at low risk for adverse events
Is the Oakland score a valid tool to assess the risk of adverse outcomes in adult patients with acute lower GI bleed (LGIB)?
Is ERCP indicated in gallstone pancreatitis without cholangitis?
How necessary is endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy in acute gallstone pancreatitis?
Timing of endoscopy for acute upper GI bleeding
In high-risk patients hospitalized with upper GI bleeding, is earlier endoscopy beneficial?
A pill for C. difficile works by increasing microbiome diversity
“I think this marks a moment in this space where we’re going to have better, safer, and more available options for patients.”
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.
Should hospitalists use albumin to treat non-SBP infections in patients with cirrhosis?
Study data suggest that albumin may be beneficial in improving renal and circulatory function.
COVID-19: New GI symptoms don’t raise death risk in IBD
International registry data show new onset of GI symptoms is common in IBD patients with COVID-19 regardless of IBD disease status.